Mistakes in coding for Coumadin monitoring can cause denials or, even worse, compliance problems. There are five major areas where practices most often make mistakes, says Lisa Johnson, CPC, CCS-P, senior consultant at Gates, Moore & Company in Atlanta.
The nurse, ancillary staff or physician must see the patient face-to-face and sufficiently document the encounter to bill the appropriate E/M code. If the patient comes to the office just for the test, but the results and recommendations are given by phone, the only code that may be reported is 85610-QW.
Most carriers consider the finger stick incidental to the procedure and will not pay for it separately. Check with carriers for their billing specifications.
Merely writing "VP for Protime" or "Pt on Coumadin" in a patient's chart is insufficient documentation to code a nurse visit for Coumadin management, Johnson says.
To find the covered diagnoses for the in-office Protime test, read your Medicare carriers' local medical review policy (LMRP) for "Prothrombin Time," Johnson says. Link the proper ICD-9 code indicating the reason for the Protime test with CPT code 85610-QW on the HCFA 1500 form.
"Some offices have heard that Coumadin is now on the CLIA list, and so they are charging 85610 when they are only drawing blood (by venipuncture) and sending it off to the lab to be tested," Johnson says. That's incorrect coding: Use 85610 only for the in-office finger stick tests.
The primary diagnosis should be the medical reason the patient is having the test. Often, the primary diagnosis code for Coumadin monitoring is V58.61 (Long-term [current] use of anticoagulants). When you use that code as the primary diagnosis, you may also include a secondary diagnosis code to indicate the reason the patient is on Coumadin, such as 427.31 (Atrial fibrillation). Be sure the diagnoses listed on the claim form reflect what is documented in the medical record regarding the reason for the visit and/or the service billed.